# A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers

> **NCT01247883** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 13 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-04634817
- **DRUG:** PF-04634817

## Key facts

- **NCT ID:** NCT01247883
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2011-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247883, "A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01247883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*